Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

NCT00835120 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Bipolar Depression
Insulin Resistance

Interventions

DRUG: Pioglitazone

Sponsor

University Hospitals Cleveland Medical Center

Collaborators

[object Object]
[object Object]